Research Alliance Corp. II (the “ Company ”) (NASDAQ: RACB), a special purpose acquisition company, today announced that, the Company will redeem all of its outstanding shares of Class A Common Stock, par value $0.0001, issued by the Company in its initial public o...
Globally focused radiopharmaceutical company achieves significant milestone to accelerate the operationalization of their 80,000 sq ft radioligand manufacturing facility POINT Biopharma Inc. (POINT), a radiopharmaceutical company dedicated to bringing the many benefits of pr...
Research Alliance Corp. II (Nasdaq:RACB) (the “Company”) announced today that on March 22, 2021 it closed its initial public offering of 14,950,000 shares of Class A common stock, including 1,950,000 shares issued pursuant to the exercise by the underwriters of their over-...
News, Short Squeeze, Breakout and More Instantly...
Research Alliance Corp. II Company Name:
RACB Stock Symbol:
NASDAQ Market:
Research Alliance Corp. II (the “ Company ”) (NASDAQ: RACB), a special purpose acquisition company, today announced that, the Company will redeem all of its outstanding shares of Class A Common Stock, par value $0.0001, issued by the Company in its initial public o...
Globally focused radiopharmaceutical company achieves significant milestone to accelerate the operationalization of their 80,000 sq ft radioligand manufacturing facility POINT Biopharma Inc. (POINT), a radiopharmaceutical company dedicated to bringing the many benefits of pr...
Research Alliance Corp. II (Nasdaq:RACB) (the “Company”) announced today that on March 22, 2021 it closed its initial public offering of 14,950,000 shares of Class A common stock, including 1,950,000 shares issued pursuant to the exercise by the underwriters of their over-...